IVVD Chart
See on advanced chart >
About
Invivyd, Inc. was incorporated on June 3, 2020 as a Delaware corporation. They are developing their lead product candidate, ADG20, for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its...
Read More
- HighlightA biopharmaceutical company that develops antibodies to neutralize SARS-CoV-2, SARS-CoV-1, and pre-emergent coronaviruses
- ExchangeNASDAQ
- Listing Date08/06/2021
- Established Date06/03/2020
- Full-time Employees94
- Address1601 Trapelo Road Suite 178 Waltham MA 02451
- Tel1-781-8190080
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals